Unlike existing treatments that block individual cytokines such as IL-4, IL-13 or IL-31, therapies targeting the OX40 pathway ...
Nearly 1 in 10 U.S. adults report having physician-diagnosed chronic head eczema, according to findings from a ...
Shawn Kwatra, M.D., Joseph W. Burnett endowed professor and chair of dermatology at the University of Maryland School of ...
The use of interleukin (IL)-23 inhibitors plays an important role in treating patients with psoriasis, as well as in treating ...
New long-term data of the investigational therapy icotrokinra show that it is able to achieve site-specific clear or almost clear skin in patients with plaque psoriasis, according to results of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback